Moberg Pharma has introduced share-based incentive schemes comprising warrants and employee stock options. The schemes are designed to promote the company’s long-term interests by incentivising and rewarding certain Directors, senior executives and other employees. The stock options have been allocated free of charge.
All permanent employees who have been employed by Moberg Pharma for more than 12 months are either shareholders or covered by Moberg Pharma’s incentive schemes.
At December 30, 2012 468,076 allocated employee stock options were outstanding (of which 187,076 were vested). These stock options are divided into eightseries, of which four have an exercise of SEK 32.75 per share, one has an exercise price of SEK 29.00 per share, one has an exercise price of SEK 16.55 per share, one has an exercise price of SEK 32.22 per share and one has an exercise price of SEK 42.81 per share. The stock options were issued by the subsidiary company Moberg Pharma Incentives AB. Each option entitles the holder to subscribe for one warrant, which in turn gives the holder the right to subscribe for two ordinary shares of the company for stock option programs 2008-2010 and gives the holder the right to subscribe for one ordinary share of the company for stock option program 2011:1, 2012:1 and 2012:2. The total number of outstanding warrants at December 30, 2012 was 600,678 (representing 847,847 shares).